文献速递胃肠外科急腹症与外科感染围术期管理与 ERAS

优化急性阑尾炎患者抗生素管理:一项质量改进研究

Optimizing antibiotic management for patients with acute appendicitis: A quality improvement study.
PubMed 文献 · Surgery · 2024-02-26

该多中心质量改进项目通过更新电子病历医嘱以鼓励术前使用窄谱抗生素,并对医生进行教育,旨在减少无并发症急性阑尾炎患者使用哌拉西林-他唑巴坦而不增加手术部位感染。干预6个月后,术前哌拉西林-他唑巴坦使用率从51.4%降至20.1%(P<.001),手术部位感染率无显著差异。

要点

  • 干预后术前哌拉西林-他唑巴坦使用率从51.4%降至20.1%(P<.001)。
  • 浅表、深部和器官腔隙手术部位感染率干预前后均无显著差异。
  • 30天再入院、再手术和艰难梭菌感染率两组也无差异。

核心结论

  • 该质量改进干预成功减少了急性阑尾炎患者哌拉西林-他唑巴坦的使用,且未增加手术部位感染率。

研究设计与样本

  • 多中心质量改进项目,比较干预前6个月与干预后6个月接受腹腔镜阑尾切除术的患者。
  • 干预前组352例,干预后组369例。
  • 干预包括更新电子病历医嘱以鼓励术前使用窄谱抗生素,以及对医生进行急性阑尾炎抗生素选择教育。

主要发现

  • 术前哌拉西林-他唑巴坦使用率干预前为51.4%,干预后为20.1%(P<.001)。
  • 浅表手术部位感染率干预前为1.4%,干预后为0.8%(P=.50)。
  • 深部手术部位感染率干预前为1.1%,干预后为0.0%(P=.06)。
  • 器官腔隙手术部位感染率干预前为3.1%,干预后为3.0%(P>.99)。
  • 30天再入院、再手术和艰难梭菌感染率两组间无差异。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To decrease surgical site infections after appendectomy for acute appendicitis, preoperative broad-spectrum antibiotics are often used in clinical practice. However, this treatment strategy has come under scrutiny because of increasing rates of antibiotic-resistant infections. METHODS: The aim of this multisite quality improvement project was to decrease the treatment of uncomplicated acute appendicitis with piperacillin-tazobactam without increasing the rate of surgical site infections. Our quality improvement intervention had 2 distinct components: (1) updating electronic health record orders to encourage preoperative administration of narrow-spectrum antibiotics and (2) educating surgeons and emergency department clinicians about selecting appropriate antibiotic therapy for acute appendicitis. Patient demographics, clinical characteristics, and outcomes were compared 6 months before and after implementation of the quality improvement intervention. RESULTS: A total of 352 laparoscopic appendectomies were performed during the 6-month preintervention period, and 369 were performed during the 6-month postintervention period. The preintervention period and postintervention period groups had similar baseline demographics, vital signs, and laboratory test values. The rate of preoperative piperacillin-tazobactam administration significantly decreased after the intervention (51.4% preintervention period vs 20.1% postintervention period, P < .001). The rate of surgical site infections was similar in both groups (superficial surgical site infections = 1.4% preintervention period vs 0.8% postintervention period, P = .50; deep surgical site infections = 1.1% preintervention period vs 0.0% postintervention period, P = .06; and organ space surgical site infections = 3.1% preintervention period vs 3.0% postintervention period, P > .99). Rates of 30-day readmission, reoperation, and Clostridioides difficile infection also did not differ between groups. CONCLUSION: Our quality improvement intervention successfully decreased piperacillin-tazobactam administration without increasing the rate of surgical site infections in patients with acute appendicitis.

来源:Surgery,查看原文。版权归原作者所有。

引用

  1. Beckermann J, Linnaus ME, Swartz H, et al. Optimizing antibiotic management for patients with acute appendicitis: A quality improvement study. Surgery. 2024. PMID: 38413304. doi:10.1016/j.surg.2024.01.010

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。